What is better for predilatation in bioresorbable vascular scaffold implantation: a non-compliant or a compliant balloon?
| Autor: | Emin Evren Özcan, Erdem Özel, Samet Uyar, Omer Senarslan, Ali Öztürk, Ahmet Taştan |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
medicine.medical_specialty
Acute coronary syndrome compliant balloon medicine.diagnostic_test business.industry medicine.medical_treatment Percutaneous coronary intervention medicine.disease Balloon Thrombosis Surgery Angina Lesion predilatation medicine non-compliant balloon Fluoroscopy bioresorbable vascular scaffold Myocardial infarction Radiology medicine.symptom Cardiology and Cardiovascular Medicine business Original Investigation |
| Zdroj: | Anatolian Journal of Cardiology |
| ISSN: | 2149-2271 2149-2263 |
| Popis: | Objective The bioresorbable vascular scaffold system (BVS) is a fully absorbable vascular treatment system. In this study, we aimed to compare the periprocedural effectiveness and long term results of non-compliant balloon (NCB) and compliant balloon (CB) systems, which are used for predilatation before BVS implantation. Methods One hundred forty-six BVS-treated lesions from 119 patients were retrospectively analyzed in the study. Patients with acute coronary syndrome, stable angina and silent ischemia were included in the study. Lesions and patients were categorized into the NCB and CB groups according to the type of balloon used for predilatation. NCB was implemented on 72 lesions (59 patients) and CB was implemented on 74 lesions (60 patients). The two groups were compared on terms of procedural features and both in-hospital and 1-year clinical follow-up results. Chi-square and independent sample t test were performed for statistical analysis. Results There was no significant difference between the two groups in terms of patient characteristics and lesion properties. The number of postdilated lesions was significantly higher in the CB group. Procedure time, fluoroscopy time, and contrast volume were significantly lower in the NCB group. At follow-up, one patient had myocardial infarction in the CB group because of scaffold thrombosis and no mortality was observed. Conclusion Predilatation with NCB before BVS implantation reduces the need for postdilatation. In addition, use of NCB reduces the procedure time, fluoroscopy time, and contrast volume but had no effect on 1 year clinical follow-up results compared with CB. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|